EC Ophthalmology

Case Series Volume 16 Issue 4 - 2025

Evaluation of Intrastromal Autologous Blood Injection for Acute Cornea Hydrops

Júlia Teixeira Leite Pereira1, Samara Barbara Marafon1,2*, Tiago Lansini1, Sérgio Kwitko1,3 and Diane Ruschel Marinho1,3,4

1Hospital de Clínicas de Porto Alegre, RS, Brazil 2Neofocus Oftalmologia, Porto Alegre, Brazil 3Oftalmocentro, Porto Alegre, RS, Brazil 4Universidade Federal do Rio Grande do Sul, RS, Brazil

*Corresponding Author: Samara Barbara Marafon, Hospital de Clínicas de Porto Alegre, RS, Brazil.
Received: November 28, 2025; Published: December 08, 2025



Purpose: To report the outcomes of corneal intrastromal injection of autologous blood to address clefts and stromal edema caused by hydrops, to expedite the resolution and reduce its complications.

Methods: This was a retrospective case series of corneal hydrops - due to keratoconus and marginal pellucid degeneration (MPD) - treated with intrastromal injections of autologous blood. The cases have all failed to respond to conservative traditional treatment. A 3.0-cc syringe filled with the patient’s unprocessed, presently collected blood and attached to a 27-gauge needle was used to penetrate the cornea and fill the clefts and corneal edema. The follow-up ended with the resolution of the corneal hydrops. Pre- and postoperative evaluations were meticulously conducted, entailing photographic recording and corneal optical coherence tomography (OCT).

Result: The study evaluated the results of the treatment in 8 eyes, 7 patients. The mean pre-treatment corneal thickness was 1417.50 ± 432 µm (range 796 - 1920 µm). Following treatment, the cornea thickness was 1020 ± 328 µm (range 772 - 1652) at seven days and 762.50 ± 460.44 µm (range 384 - 1853) 30 days post intrastromal injection. There was a significant reduction from pre-op to thirty days after treatment in the cornea thickness of 655.00 ± 527.65 µm (p = 0.010). Six of the eight eyes exhibited a reduction in corneal thickness of over 50% within 30 days post-surgery. The median time to resolution was 4.2 weeks. No intraoperative or postoperative complications were associated with this procedure.

Conclusion: This case series demonstrates that intrastromal autologous blood is a promising and viable treatment option for managing corneal hydrops, particularly when traditional approaches have proven ineffective. The treatment is cost-effective and could be used as an alternative to reduce symptoms and improve quality of life while on the cornea waiting list. Furthermore, this series adds to the literature on OCT findings in corneal hydrops and the intrastromal application of autologous blood to address Descemet membrane (DM) rupture in acute corneal hydrops.

 Keywords: Keratoconus; Hydrops; Autologous Blood; Corneal Graft; Corneal Transplantation

  1. Fan Gaskin JC., et al. “Acute corneal hydrops in keratoconus - new perspectives”. American Journal of Ophthalmology 5 (2014): 921-928.
  2. Basu S., et al. “Anterior segment optical coherence tomography features of acute corneal hydrops”. Cornea 5 (2012): 479-485.
  3. Tuft SJ., et al. “Acute corneal hydrops in keratoconus”. Ophthalmology 10 (1994): 1738-1744.
  4. Nakagawa T., et al. “Ultrasound biomicroscopic examination of acute hydrops in patients with keratoconus”. American Journal of Ophthalmology6 (2006): 1134-1136.
  5. Rubsamen PE and McLeish WM. “Keratoconus with acute hydrops and perforation. Brief case report”. Cornea 1 (1991): 83-84.
  6. Higuchi A. “Autologous serum and serum components”. Investigative Ophthalmology and Visual Science14 (2018): DES121-DES129.
  7. Dantas PEC and Nishiwaki-Dantas MC. “Spontaneous bilateral corneal perforation of acute hydrops in keratoconus”. Eye and Contact Lens1 (2004): 40-41.
  8. Donnenfeld ED., et al. “Infectious keratitis with corneal perforation associated with corneal hydrops and contact lens wear in keratoconus”. British Journal of Ophthalmology5 (1996): 409-412.
  9. Basu S., et al. “Intracameral perfluoropropane gas in the treatment of acute corneal hydrops”. Ophthalmology 5 (2011): 934-939.
  10. Rajaraman R., et al. “Efficacy and safety of intracameral perfluoropropane (C3F8) tamponade and compression sutures for the management of acute corneal hydrops”. Cornea 3 (2009): 317-320.
  11. Daza J., et al. “Application of compression sutures with a modified technique for rapid resolution of large (Grade III) hydrops: A prospective interventional study”. Cornea 1 (2024): 20-25.
  12. Alio JL., et al. “Treatment of severe keratoconus hydrops with intracameral platelet-rich plasma injection”. Cornea12 (2019): 1595-1598.
  13. Regis LM., et al. “Hidropsia corneana aguda gigante: relato de um caso tratado com injeçäo de sangue autólogo/Use of autologous blood as treatment of giant acute hydrops: A case report”. Revista Brasileira de Oftalmologia (1998).
  14. Vajpayee RB., et al. “Intrastromal fluid drainage with air tamponade: anterior segment optical coherence tomography guided technique for the management of acute corneal hydrops”. British Journal of Ophthalmology 7 (2013): 834-836.

Samara Barbara Marafon., et al. “Evaluation of Intrastromal Autologous Blood Injection for Acute Cornea Hydrops”. EC Ophthalmology  16.4 (2025): 01-08.